AZN Cash & Equivalents
AstraZeneca PLC Ordinary Shares · Cash & Equivalents
AZN Cash & Equivalents
Latest reported$5.71Bperiod ending
AZN FY Cash & Equivalents ($129.24M → $5.71B)
Annual Cash & Equivalents
High-resolution chart · PNG
AZN cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 5,711,000,000 | |
| 5,488,000,000 | |
| 5,840,000,000 | |
| 6,166,000,000 | |
| 6,329,000,000 | |
| 7,832,000,000 | |
| 5,368,000,000 | |
| 4,831,000,000 | |
| 3,324,000,000 | |
| 5,018,000,000 | |
| 6,240,000,000 | |
| 6,360,000,000 | |
| 9,217,000,000 | |
| 7,701,000,000 | |
| 7,571,000,000 | |
| 11,068,000,000 | |
| 9,918,000,000 | |
| 4,286,000,000 | |
| 5,867,000,000 | |
| 7,103,000,000 | |
| 4,979,000,000 | |
| 4,067,000,000 | |
| 733,000,000 | |
| 726,000,000 | |
| 1,007,943,507 | |
| 1,021,627,434 | |
| 428,788,663 | |
| 341,937,090 | |
| 500,892,680 | |
| 443,538,719 | |
| 251,869,707 | |
| 856,745,305 | |
| 1,351,991,006 | |
| 465,624,194 | |
| 473,410,426 | |
| 129,238,841 |